Whole-Genome Sequencing in Cancer: Feasibility, Actionability & Impact on Survival

Archyde Recent advancements in whole-genome sequencing (WGS) are making significant strides in the clinical management of solid tumors. A comprehensive study involving 935 patients, conducted between January 2021 and November 2022, … Read More You can read the full story here: <p><strong>Whole-Genome Sequencing in Cancer: Feasibility, Actionability & Impact on Survival</strong></p>. Source link

WASP Protein & T Cell Lymphoma: Tumor Suppressor Role

Matteo Menotti Present address: Cell Signalling Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester,… The post WASP Protein & T Cell Lymphoma: Tumor Suppressor Role appeared first on Archynetys. Source link

Artificial intelligence-guided design of LNPs for in vivo targeted mRNA delivery via analysis of the spatial conformation of ionizable lipids

Su, L.-J. et al. Delivery of mRNA for cancer therapy: progress and prospects. Nano Today 53, 102013 (2023). Article  CAS  Google Scholar  Huang, X. G. et al. The landscape of mRNA nanomedicine. Nat. Med. 28, 2273–2287 (2022). Article  CAS  PubMed  Google Scholar  Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. … Read more

Zolbetuximab & Nivolumab: Phase 2 Trial in CLDN18.2+ Gastric Cancer

Competing interests K.S. reports receiving personal fees for consulting and advisory roles from Bristol Myers Squibb,… The post Zolbetuximab & Nivolumab: Phase 2 Trial in CLDN18.2+ Gastric Cancer appeared first on Archynetys. Source link

Serum p-tau181 Levels in AL and ATTR Amyloidosis & Related Neuropathies

Archyde Recent research has highlighted the potential of blood phosphorylated tau (p-tau) levels as biomarkers in diagnosing immunoglobulin light chain (AL) and transthyretin (ATTR) amyloidosis. This advancement could enhance the clinical approach to these conditions, which are characterized by the abnormal accumulation of amyloid proteins that can lead to significant organ damage and dysfunction. The … Read more

Exploring the Future of Cancer Immunotherapy: Advances in Neoantigen Vaccines and T Cell Responses

Archyde [gpt3] CATEGORY Health CATEGORY FOCUS Public health, medicine, hospitals, research, mental health, outbreaks, safety advisories, health policy, and wellness topics. Highest accuracy threshold, cautious language, and no medical advice. HEALTH… You can read the full story here: Exploring the Future of Cancer Immunotherapy: Advances in Neoantigen Vaccines and T Cell Responses. Source link

PCSK9 Base Editing for Hypercholesterolemia: Phase 1 Trial Results

Archyde A new approach to gene editing, known as base editing, has demonstrated initial success in lowering cholesterol levels in individuals with familial hypercholesterolemia, a common genetic condition. The findings, published… You can read the full story here: PCSK9 Base Editing for Hypercholesterolemia: Phase 1 Trial Results. Source link

Efficient cardiac MRI multi-structure segmentation for cardiovascular assessment with limited annotation by integrating data-level and network-level consistency

Elliott, P. M. et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Kardiol. Polska 72, 1054–1126 (2014).. Lalande, A. et al. Deep learning methods for automatic evaluation of delayed enhancement-MRI. The results of the emidec challenge. Med. Image Anal. 79, 102428 (2022). Google Scholar  Bernard, O. et al. Deep learning techniques for … Read more

Understanding the Global Burden and Vaccine Developments for Dengue Fever

Archyde The Butantan Institute’s single-dose tetravalent dengue vaccine has emerged as a significant development in the fight against dengue fever, a disease that poses a major health threat in endemic regions.… You can read the full story here: Understanding the Global Burden and Vaccine Developments for Dengue Fever. Source link

Understanding the Role of TREM2 in Alzheimer’s Disease: Insights and Implications

Archyde Recent advances in Alzheimer’s disease research have spotlighted the TREM2 agonistic antibody AL002, which has shown promise in early-stage clinical trials. This phase 2 randomized trial aimed to assess the… You can read the full story here: Understanding the Role of TREM2 in Alzheimer’s Disease: Insights and Implications. Source link